- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
An evaluation of durvalumab across the spectrum of urothelial carcinoma.
September 18, 2024
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
September 18, 2024
"…I Wish Someone Told Me About That…": A Qualitative Assessment of the Educational Needs of Patients Undergoing Cystectomy.
September 17, 2024
The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysis.
September 17, 2024
Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer.
September 16, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial Cancer.
September 16, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study.
September 16, 2024
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints.
September 13, 2024
The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer.
September 12, 2024
Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer.
September 12, 2024
Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review.
September 12, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.
September 11, 2024
Stent vs Stent-Less Ileal Conduits After Radical Cystectomy: Is There a Difference in Early Postoperative Outcomes?
September 11, 2024
Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges.
September 11, 2024
The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature.
September 11, 2024